TrialsgrambetaRCTs are beautiful

CONSENSUS

1987

Cooperative North Scandinavian Enalapril Survival Study

In 253 patients with NYHA IV heart failure, enalapril reduced 6-month mortality versus placebo.

Result

Mortality at 6 months
Absolute difference
18 points
Effect estimate

RRR40

The absolute difference is derived from the event rates.

Also reported: Effect maintained at 12 months.

Original publication
Subtopic
RAAS inhibition
Design
Double-blind RCT, terminated early
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
CONSENSUS Trial Study Group. N Engl J Med. 1987;316(23):1429-1435.doi 10.1056/NEJM198706043162301

Discussion & critique

Small but transformative: opened the ACE inhibitor era for HF. Limited to severe HF; SOLVD generalised to milder disease.

Discussed in podcasts